TWi Pharmaceuticals, Inc.
11 drugs in NADAC|11 Generic,0 Brand
TWi Pharmaceuticals, Inc. lists 11 NDCs in the CMS NADAC file (11 generic, 0 brand), at an average NADAC of $0.14 per unit, with a week-over-week move of -0.7% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
11
11G / 0B
Avg Price / Unit
$0.1379
$0.08 – $0.27
Avg 7d Change
-0.67%
Across 5 drugs with changes
7d Activity
of 11 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
bupropion hydrochloride market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Aminoketone therapeutic class
Review the broader class where TWi Pharmaceuticals, Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does TWi Pharmaceuticals, Inc. make?
TWi Pharmaceuticals, Inc. lists 11 NDCs in the CMS NADAC file — 11 generic and 0 brand products.
What is the average price of TWi Pharmaceuticals, Inc. drugs?
The average NADAC across TWi Pharmaceuticals, Inc.'s portfolio is $0.1379 per unit, ranging from $0.0779 to $0.2673.
What types of drugs does TWi Pharmaceuticals, Inc. make?
TWi Pharmaceuticals, Inc. makes drugs across 4 FDA pharmacologic classes. The most common by NDC count are Aminoketone (6), Central alpha-2 Adrenergic Agonist (2), Antimetabolite Immunosuppressant (2), Phosphate Binder (1).
Has TWi Pharmaceuticals, Inc. had any drug recalls?
No FDA enforcement recalls are matched to TWi Pharmaceuticals, Inc. in the openFDA feed.
How has TWi Pharmaceuticals, Inc.'s pricing changed recently?
Over the past 7 days, 2 TWi Pharmaceuticals, Inc. products rose and 3 fell, with a portfolio-wide average change of -0.7%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
GUANFACINE 2 MG TABLET Guanfacine | $0.2673 per EA | -1.79% |
MYCOPHENOLIC ACID DR 360 MG TB mycophenolic acid | $0.2216 per EA | -2.17% |
SEVELAMER CARBONATE 800 MG TAB Sevelamer Carbonate | $0.2140 per EA | -2.12% |
GUANFACINE 1 MG TABLET Guanfacine | $0.1466 per EA | +1.62% |
BUPROPION HCL XL 300 MG TABLET bupropion hydrochloride | $0.1115 per EA | — |
BUPROPION HCL XL 300 MG TABLET bupropion hydrochloride | $0.1115 per EA | — |
BUPROPION HCL XL 300 MG TABLET bupropion hydrochloride | $0.1115 per EA | — |
MYCOPHENOLIC ACID DR 180 MG TB mycophenolic acid | $0.0996 per EA | +1.09% |
BUPROPION HCL XL 150 MG TABLET bupropion hydrochloride | $0.0779 per EA | — |
BUPROPION HCL XL 150 MG TABLET bupropion hydrochloride | $0.0779 per EA | — |
BUPROPION HCL XL 150 MG TABLET bupropion hydrochloride | $0.0779 per EA | — |